Culver Productions | IRC Value Prop Test
page-template-default,page,page-id-15859,ajax_fade,page_not_loaded,,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-6.5.0,vc_responsive

IRC Value Prop Test


Hospitals, health systems, academic medical centers and multi-specialty group practices have often turned over their patients with end stage renal disease to large dialysis organizations where care for common co-morbidities like diabetes, heart disease and depression are an after thought.


These same health system players relinquish control of those patients and the significant revenue streams they generate to these dialysis providers.


The result is not optimal for either the patient or the health system.

New approach to care

New Revenue Opportunities


People with end stage renal disease most often are discharged by hospital planners to large dialysis organizations.  These dialysis organizations are separate and apart from the patient’s health care system.  The dialysis organizations are designed to care for the patient’s kidneys but they are poorly equipped to care for diseases that underlie ESRD. Diseases like diabetes and heart disease both drive kidney failure but are also driven by kidney failure.  Depression is a prevalent co-morbid condition that is outside the scope of care for most dialysis organizations but accounts for a significant diminishment of proper compliance and adherence to sound self-care.


Innovative Renal Care has built a different model that integrates the full range of clinical services offered by the patient’s primary health system, from their primary care physician, to their cardiologist, their endocrinologist and their behavioral health partners.  All clinical information is housed in a single electronic health record and IRC provides supplementary behavioral Telehealth.

We have demonstrated that mortality can be reduced to 16% to 10% or less with more fully coordinated care

65% of patients would prefer in-home dialysis yet only 15% currently do

We are committed to increasing in-home dialysis to 40% – a standard currently met by European health systems